Nano-X Imaging Ltd. (NASDAQ:NNOX) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Nano-X Imaging Ltd. (NASDAQ:NNOX) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, one has issued a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $4.00.

Several research firms have recently commented on NNOX. Zacks Research upgraded Nano-X Imaging from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. D. Boral Capital restated a “buy” rating and set a $5.00 price objective on shares of Nano-X Imaging in a research report on Monday, April 20th. Alliance Global Partners downgraded shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a report on Wednesday, July 8th.

Insider Buying and Selling

In other news, CEO Erez Meltzer purchased 36,000 shares of Nano-X Imaging stock in a transaction dated Monday, July 27th. The shares were purchased at an average price of $0.93 per share, with a total value of $33,480.00. Following the transaction, the chief executive officer owned 36,000 shares in the company, valued at $33,480. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Dan S. Suesskind acquired 50,000 shares of the firm’s stock in a transaction that occurred on Monday, July 27th. The stock was acquired at an average price of $0.93 per share, for a total transaction of $46,500.00. Following the completion of the acquisition, the director directly owned 50,000 shares of the company’s stock, valued at $46,500. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. 7.74% of the stock is owned by company insiders.

Institutional Investors Weigh In On Nano-X Imaging

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE lifted its stake in shares of Nano-X Imaging by 711.1% in the 1st quarter. Bank of America Corp DE now owns 484,328 shares of the company’s stock valued at $1,099,000 after purchasing an additional 424,618 shares during the last quarter. Royal Bank of Canada raised its holdings in Nano-X Imaging by 27.8% in the 1st quarter. Royal Bank of Canada now owns 194,166 shares of the company’s stock valued at $440,000 after buying an additional 42,273 shares during the period. Sei Investments Co. purchased a new stake in Nano-X Imaging in the 1st quarter valued at about $98,000. Independent Financial Group LLC acquired a new position in Nano-X Imaging in the first quarter valued at about $26,000. Finally, Hsbc Holdings PLC purchased a new position in Nano-X Imaging during the first quarter worth about $35,000. Hedge funds and other institutional investors own 21.49% of the company’s stock.

Nano-X Imaging Price Performance

NNOX stock opened at $1.06 on Friday. Nano-X Imaging has a 1 year low of $0.73 and a 1 year high of $4.88. The firm has a market capitalization of $73.78 million, a PE ratio of -0.67 and a beta of 1.26. The business has a 50 day simple moving average of $1.32 and a 200-day simple moving average of $1.97.

Nano-X Imaging (NASDAQ:NNOX) last announced its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The company had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative return on equity of 70.96% and a negative net margin of 716.44%. On average, equities research analysts expect that Nano-X Imaging will post -0.6 EPS for the current year.

Nano-X Imaging News Summary

Here are the key news stories impacting Nano-X Imaging this week:

• Positive Sentiment: Brokerages reportedly set a price target of $4.00, substantially above Nano-X Imaging’s recent trading level. However, the target is only an indication of analyst expectations and does not offset the company’s financing and legal risks. Brokerages Set Nano-X Imaging Price Target at $4.00
• Neutral Sentiment: Nano-X Imaging priced an $8 million registered direct offering at the market price under Nasdaq rules. The proceeds could provide additional operating liquidity, but the transaction’s equity-based structure may dilute existing shareholders. The announcement also disclosed that the company is conducting a broad impairment review, which could affect reported asset values and future results. Nano-X Announces $8 Million Registered Direct Offering
• Negative Sentiment: Multiple law firms announced or promoted a securities class action against Nano-X Imaging and certain officers. The notices allege investor harm and potential securities-law violations during the March 31, 2025–April 17, 2026 class period, with an August 11, 2026 lead-plaintiff deadline. The allegations have not been proven, but the litigation creates legal costs, reputational risk and uncertainty for shareholders. Pomerantz Class Action Filing Bronstein Class Action Notice Rosen Nano-X Deadline Notice

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.